Labopharm Appoints Mark D’Souza As Chief Financial Officer

LAVAL, QC, Sept. 13 /CNW/ - Labopharm Inc. (TSX: DDS, NASDAQ:DDSS) today announced the appointment of Mark D'Souza to the position of Chief Financial Officer. Labopharm today also announced that Warren Whitehead is leaving the Company to pursue other opportunities.
MORE ON THIS TOPIC